Concordia International Corp Company Profile (TSE:CXR)

About Concordia International Corp (TSE:CXR)

Concordia International Corp logoConcordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: TSE:CXR
  • CUSIP: N/A
  • Web:
  • Market Cap: C$36.82 million
  • Outstanding Shares: 51,143,000
Average Prices:
  • 50 Day Moving Avg: C$1.49
  • 200 Day Moving Avg: C$1.72
  • 52 Week Range: C$0.70 - C$7.39
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: C$677.25 million
  • Price / Sales: 0.05
  • Book Value: C($27.60) per share
  • Price / Book: -0.03
  • EBITDA: C$326.58 million
  • Net Margins: -628.57%
  • Return on Assets: -130.11%
  • Average Volume: 125,538 shs.
  • Short Ratio: 0.8

Frequently Asked Questions for Concordia International Corp (TSE:CXR)

What is Concordia International Corp's stock symbol?

Concordia International Corp trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CXR."

How were Concordia International Corp's earnings last quarter?

Concordia International Corp (TSE:CXR) posted its earnings results on Thursday, August, 13th. The company reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.06 by $0.02. The business had revenue of $95.34 million for the quarter, compared to the consensus estimate of $87.41 million. View Concordia International Corp's Earnings History.

When will Concordia International Corp make its next earnings announcement?

Concordia International Corp is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Concordia International Corp.

Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?

4 brokers have issued 12-month price objectives for Concordia International Corp's shares. Their predictions range from C$13.50 to C$13.50. On average, they expect Concordia International Corp's share price to reach C$13.50 in the next twelve months. View Analyst Ratings for Concordia International Corp.

Who are some of Concordia International Corp's key competitors?

Who are Concordia International Corp's key executives?

Concordia International Corp's management team includes the folowing people:

  • Wayne Kreppner, President, Chief Operating Officer
  • Allan Oberman, Chief Executive Officer, Director
  • David J. Price, Chief Financial Officer
  • Graeme Duncan, President - Company's International Segment
  • Arijit Mookerjee, Managing Director, Chief Financial Officer - Operations
  • Adeel Ahmad, Chief Financial Officer of AMCo
  • Francesco Tallarico, Chief Legal Officer and Secretary
  • Jordan M. Kupinsky J.D., Non-Executive Independent Chairman of the Board
  • Douglas N. Deeth, Independent Director
  • Rochelle Fuhrmann, Independent Director

How do I buy Concordia International Corp stock?

Shares of Concordia International Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Concordia International Corp's stock price today?

One share of Concordia International Corp stock can currently be purchased for approximately C$0.72.

MarketBeat Community Rating for Concordia International Corp (TSE CXR)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  342
MarketBeat's community ratings are surveys of what our community members think about Concordia International Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Concordia International Corp (TSE:CXR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Sell Ratings
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: C$13.50
Consensus Price Target History for Concordia International Corp (TSE:CXR)
Price Target History for Concordia International Corp (TSE:CXR)
Analysts' Ratings History for Concordia International Corp (TSE:CXR)
DateFirmActionRatingPrice TargetDetails
3/16/2017ScotiabankReiterated RatingUnderperformView Rating Details
2/9/2017TD SecuritiesDowngradeHold -> ReduceView Rating Details
12/8/2016Royal Bank Of CanadaDowngradeSector Perform -> UnderperformView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellView Rating Details
8/15/2016Goldman Sachs Group IncLower Price TargetC$34.00 -> C$17.00View Rating Details
8/15/2016CIBCDowngradeSector Perform -> UnderperformView Rating Details
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details
12/3/2015MackieDowngradeHoldView Rating Details
(Data available from 10/21/2015 forward)


Earnings History for Concordia International Corp (TSE:CXR)
Earnings by Quarter for Concordia International Corp (TSE:CXR)
Earnings History by Quarter for Concordia International Corp (TSE CXR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2015Q2C$1.06C$1.04C$87.41 millionC$95.34 millionViewListenView Earnings Details
8/13/2014C$0.19C($0.03)C$24.42 millionC$28.49 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Concordia International Corp (TSE:CXR)
Current Year EPS Consensus Estimate: $0.66 EPS


Dividend History by Quarter for Concordia International Corp (TSE CXR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Erin Colleen O'neilDirectorSell191C$1.74C$332.34
5/16/2017Graeme Neville DuncanDirectorSell7,065C$1.91C$13,494.15
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50
(Data available from 1/1/2013 forward)


Headline Trends for Concordia International Corp (TSE:CXR)
Latest Headlines for Concordia International Corp (TSE:CXR)
DateHeadline logoTSX Creeps Closer To Record Highs -- Canadian Commentary - October 20 at 7:12 PM logoIIROC Trade Resumption - CXR - October 20 at 7:11 PM logoUpdate: TSX Posts Modest 30-Point Gain in Broad-Based Advance Led by Financials & Industrials - October 12 at 5:20 AM logoCanadian Stocks Turn Positive After EIA Report - Canadian Commentary - October 4 at 11:20 AM logoCanadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary - September 27 at 6:50 PM logoETFs with exposure to Concordia International Corp. : September 6, 2017 - September 6 at 12:19 AM logoConcordia International Corp. Announces Release Date for DELIVER Strategy - PR Newswire (press release) - September 1 at 11:00 PM logoCanadian Stocks Are Rising On Strong GDP Data - Canadian Commentary - August 31 at 5:37 PM logoConcordia International Corp. :CXR-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 18, 2017 - August 18 at 5:40 PM logoRedHill Biopharma Announces US Commercialization Agreement for FDA-Approved GI Product Esomeprazole ... - Nasdaq - August 17 at 4:32 PM logoSHAREHOLDER ALERT: Morganti Legal, PC Advises Shareholders of Concordia International Corp. of a Motion ... - Business Wire (press release) - August 15 at 6:24 PM logoEdited Transcript of CXR.TO earnings conference call or presentation 11-Aug-17 12:30pm GMT - August 11 at 11:12 PM logoConcordia International Corp (TSE:CXR) Set to Announce Earnings on Friday - August 4 at 7:12 AM logoConcordia International Corp. :CXR-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017 - August 3 at 7:15 PM logoShort seller Cohodes hits Canada again with latest target -Exchange Income - July 5 at 6:28 PM logoConcordia Shares Lead TSX Gainers on Corporate Update - June 22 at 10:32 AM logoConcordia International Corp. Announces Results of First CMA Stop/Go Decision - PR Newswire (press release) - May 31 at 9:39 PM logoConcordia International Corp. Announces Two New Appointments to ... - PR Newswire (press release) - May 4 at 8:02 AM logoCanadian Stocks Are Extending Recent Losses - Canadian Commentary - April 13 at 11:46 AM logoCanadian Stocks Are Paring Early Gains - Canadian Commentary - March 17 at 9:58 PM logoStocks Rally On Oil Rebound, Sober Fed -- Canadian Commentary - March 15 at 5:04 PM logoQ4 2016 Concordia International Corp Earnings Release - Before Market Open - March 15 at 9:47 AM logoRedHill Biopharma's Co-Promotion Partner Concordia Announces ... - Nasdaq - March 7 at 4:34 PM logoProfile: Concordia International Corp (CXR.TO) - February 7 at 10:47 PM logoCanadian Stocks Are Extending Their Losses In Early Trade - Canadian Commentary - Nasdaq - January 31 at 5:15 PM logoTSX Slightly Higher, Blackberry Makes Bet On Self-driving Cars - December 20 at 5:23 PM



Concordia International Corp (CXR) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.